Plant-based vaccines: Expression and oral immunogenicity

被引:2
作者
Mason, HS [1 ]
机构
[1] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA
关键词
plant vaccine; transgenic potato; enterotoxic E. coli; Norwalk virus capsid protein; hepatitis B surface antigen; virus-like particle;
D O I
10.1079/IVP2002294
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The use of plants for production and delivery of vaccine proteins has shown promise in research conducted during the past decade. Genes encoding bacterial and viral antigens are faithfully expressed, processed, and assembled in plant cells to form immunogenic proteins. Studies in animals and humans showed that ingestion of transgenic potato containing vaccine proteins caused production of antigen-specific antibodies in serum and mucosal secretions. Future studies must aim to improve antigen expression and to develop processes to formulate plant material for antigen stability and convenient oral delivery. Furthermore, production methods should ensure the containment of pharmaceutical crops and prevent contamination of the food supply.
引用
收藏
页码:237 / 240
页数:4
相关论文
共 50 条
  • [21] The Immunogenicity of Coxsackievirus A6 (D3a Sub-Genotype) Virus-Like Particle and mRNA Vaccines
    Lu, Huanhuan
    Xiao, Jinbo
    Song, Jingdong
    Song, Yang
    Li, Hai
    Ren, Hu
    Li, Jichen
    Cong, Ruyi
    Li, Hangwen
    Fang, Yi
    Yan, Dongmei
    Zhu, Shuangli
    Sun, Qiang
    Liu, Ying
    Zhang, Yong
    JOURNAL OF MEDICAL VIROLOGY, 2025, 97 (02)
  • [22] Safety and immunogenicity of a plant-derived rotavirus-like particle vaccine in adults, toddlers and infants
    Kurokawa, Natsuki
    Robinson, Michelle K.
    Bernard, Catherine
    Kawaguchi, Yutaka
    Koujin, Yoshito
    Koen, Anthonet
    Madhi, Shabir
    Polasek, Thomas M.
    McNeal, Monica
    Dargis, Michele
    Couture, Manon M-J
    Trepanier, Sonia
    Forrest, Bruce D.
    Tsutsui, Naohisa
    VACCINE, 2021, 39 (39) : 5513 - 5523
  • [23] Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: Immunogenicity and protective efficacy in macaques
    Dale, CJ
    Liu, XSS
    De Rose, R
    Purcell, DFJ
    Anderson, J
    Xu, Y
    Leggatt, GR
    Frazer, IH
    Kent, SJ
    VIROLOGY, 2002, 301 (01) : 176 - 187
  • [24] Codelivery of improved immune complex and virus-like particle vaccines containing Zika virus envelope domain III synergistically enhances immunogenicity
    Diamos, Andrew G.
    Pardhe, Mary D.
    Sun, Haiyan
    Hunter, Joseph G. L.
    Mor, Tsafrir
    Meador, Lydia
    Kilbourne, Jacquelyn
    Chen, Qiang
    Mason, Hugh S.
    VACCINE, 2020, 38 (18) : 3455 - 3463
  • [25] Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice
    Huang, Z
    Santi, L
    LePore, K
    Kilbourne, J
    Arntzen, CJ
    Mason, HS
    VACCINE, 2006, 24 (14) : 2506 - 2513
  • [26] Immunogenicity of plant-produced African horse sickness virus-like particles: implications for a novel vaccine
    Dennis, Susan J.
    Meyers, Ann E.
    Guthrie, Alan J.
    Hitzeroth, Inga I.
    Rybicki, Edward P.
    PLANT BIOTECHNOLOGY JOURNAL, 2018, 16 (02) : 442 - 450
  • [27] Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models
    Aldo Venuti
    Gianfranca Curzio
    Luciano Mariani
    Francesca Paolini
    Cancer Immunology, Immunotherapy, 2015, 64 : 1329 - 1338
  • [28] Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models
    Venuti, Aldo
    Curzio, Gianfranca
    Mariani, Luciano
    Paolini, Francesca
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (10) : 1329 - 1338
  • [29] Virus-like particle and DNA-based candidate AIDS vaccines
    Yao, QZ
    Bu, ZG
    Vzorov, A
    Yang, CL
    Compans, RW
    VACCINE, 2003, 21 (7-8) : 638 - 643
  • [30] The Potential of Plant-Produced Virus-like Particle Vaccines for African Horse Sickness and Other Equine Orbiviruses
    Pitchers, Kieran G.
    Boakye, Oliver D.
    Campeotto, Ivan
    Daly, Janet M.
    PATHOGENS, 2024, 13 (06):